B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. - Wikidata - wikimedia - TriplyDB

B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.

B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.

http://www.wikidata.org/entity/Q40662745

about

Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspnea Considerations for initial therapy in the treatment of acute heart failure Recent developments in non-invasive cardiology Predicting the occurrence of major adverse cardiac events within 30 days of a vascular surgery: an empirical comparison of the minimum p value method and ROC curve approach using individual patient data meta-analysis.Comparability of Results between Point-of-Care and Automated Instruments to Measure B-type Natriuretic Peptide.Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study.Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure.Effects of thoracic epidural analgesia on plasma cAMP and cGMP levels in patients with heart failure.The biological variation of N-terminal pro-brain natriuretic peptide in postmenopausal women with type 2 diabetes: a case control study.Increased peak postoperative B-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery.BNP was associated with ischemic myocardial scintigraphy and death in patients at chest pain unit Management of acute decompensated heart failure in the emergency department.The evolving role of nesiritide in advanced or decompensated heart failure.ProBNP-derived peptides in cardiac disease.The utility of BNP in clinical practice.B-type natriuretic peptide measurement in heart failure.BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.Brain natriuretic peptide in the contemporary management of congestive heart failure.Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room?Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool.Acutely decompensated congestive heart failure: new therapies for an old problem.B-type natriuretic peptide in the diagnosis of heart failure in the emergency department.Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.Nonheart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis.Physiology and clinical significance of natriuretic hormones Serum high-sensitivity C-reactive protein, amyloid associated protein and N-terminal proBNP levels do not predict reversible myocardial ischaemia.Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting.Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine.Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.Elevated N-terminal pro-brain natriuretic peptide in Mycobacterium tuberculosis pulmonary infection without myocardial dysfunction.Natriuretic peptide testing in emergency settings.Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting.Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study.Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6.

P2860

Q24650348-F0AD4E7A-EDB3-4C0C-AA4B-B41AA312095A Q26745756-300B0C63-A19D-4EBA-9A1A-B83D8933CDD1 Q26778120-59CFFB6B-00E8-4796-92AE-2C4264D3F717 Q30458413-75E2B429-32EC-48BB-BE70-063FF80464A4 Q31073733-95A748E4-A52F-4AFE-A478-4E75201B188E Q33774275-241F9AB5-1A9F-42E3-A0DF-A260CC9F5C57 Q33902623-F88A700A-2DD7-4EF8-9337-745F3933F9FE Q33932889-C04C34D4-8091-4726-A0B9-2459447C2D83 Q34027034-A6818BA3-7CD6-4241-9162-D65489525663 Q34190826-C4D89B38-C40A-4445-8D93-855CD654F2B1 Q34297057-FC57F6BD-56AF-4151-BC00-FA5155F82E53 Q34461640-F9EED94E-875A-4C26-9001-B64F040AF890 Q34477250-4B503853-75F4-48EB-8E0F-AA2E08EABA57 Q34715439-84F5ED94-CEF0-41D4-AADC-ACD381B89716 Q35292436-1AEEC194-8A90-4C18-B24C-AF0491B4938C Q35561935-44BCEC3F-EB9C-4DAF-B25B-67F23A2B0ED8 Q35574016-8232D33B-611C-4133-A7C4-D88B1DA2D35C Q35847164-D5526331-38BF-4A5C-A4DB-92DF9C39B45B Q35856451-156268D5-D705-4806-94C6-B0C853D91E07 Q35911696-C0255E2D-A61C-45A5-BD68-764040D8F30F Q35987052-D61652DF-32FD-4A2D-BF3C-A181A6F6B882 Q36050481-AF655062-7386-4EFD-B5CA-C26587B9F600 Q36204135-51905564-3ED3-4D0A-A09D-F1B61C65253D Q36212104-9667C137-FAE6-4A32-9652-2A3A240483A6 Q36223832-10023A11-5728-480A-8D17-0153170A574B Q36266039-626E11D9-B4F5-45FF-98DF-0F7178B51352 Q36466739-663C1240-E298-4AB8-8672-D0B35D3FB41D Q36716456-04860823-4571-4201-8816-86801ADDC94A Q36861287-E0B947DC-118F-48F3-9EDE-1E70A0B88794 Q36862282-2EAB3AD0-C584-4F4E-A807-2551BC9C5DD2 Q37041836-31E3BBAB-3A62-4930-9DF4-B47B37D077AF Q37092258-62B711F4-E144-4481-9416-636638FD3405 Q37184026-F9EE804C-2191-4D20-9E79-25F0DF091892 Q37207285-DE2CC646-D28F-4E5B-AA22-75644E4CADD0 Q37229555-BD76A850-2410-468D-A005-93C7CAE5F4EA Q37252868-B775695D-7914-4DB9-B5D6-697AB92C8564 Q37326743-596FF5F2-EAB7-452A-B5F5-99E13838ECBA Q37337440-3DD6748D-F84F-48DC-AB36-A8CC9FED8E9E Q37360329-1329A785-AA07-41F2-A9BA-14DA2FB40F18 Q37461040-497BB6A5-0320-44FA-954E-FED8D29DCE5A

P2860

B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.

http://www.wikidata.org/entity/Q40662745

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

B-type natriuretic peptide pre ...... gency department with dyspnea.

@en

type

label

B-type natriuretic peptide pre ...... gency department with dyspnea.

@en

prefLabel

B-type natriuretic peptide pre ...... gency department with dyspnea.

@en

P1433

Q40662745-D7B15E53-79A8-4310-BF93-D1380B7D5D52

P1476

Q40662745-6079148E-A492-45BD-83F3-60C6FFB86FAF

P2093

Q40662745-05084891-54B6-49D2-B093-64974C18C0C2

Q40662745-1DE2DD76-1B25-46DB-BC1E-4263AF29ED27

Q40662745-2E2BF02C-FF82-4011-941C-1945E43C36EC

Q40662745-5C0FF60D-9E8D-47FB-825E-C3A49213AE7E

Q40662745-618A4327-1F66-4B5C-B39D-01CEC18F5FB6

Q40662745-997BA4F5-7195-4423-B118-0FB9419F505E

Q40662745-CA355D4A-917B-4D70-920E-507757BAA652

Q40662745-FBAF6396-36D7-4D8D-BF37-8FFA11D79BCB

P304

Q40662745-8AC91D26-5772-4FED-AFCB-1A6A56CB160A

P31

Q40662745-30872D39-8054-4BFC-BEC1-B8914B171116

P356

Q40662745-18DCE29E-3A86-43A6-8AD4-D8F93E3575A2

P407

Q40662745-D38999DB-CCB7-4554-BAA6-AD1B4DB0883F

P433

Q40662745-1A44971D-61A1-49E0-8CD2-D73A23D26BD2

P478

Q40662745-59C5B930-F198-4FA9-B499-E83C2653E4CB

P577

Q40662745-C45A8F2B-FB61-4209-B87F-C6BCFAA2A636

P5875

Q40662745-72990099-D359-4237-B4CC-FEDB3795D14C

P698

Q40662745-91B0D6E2-B692-4B0E-9945-B0B0C3ED8D1C

P921

Q40662745-B437F595-442A-4AD4-BE17-6376ED3A43E5

P356

MEM.2002.121483

P1433

Annals of Emergency Medicine

P1476

B-type natriuretic peptide pre ...... gency department with dyspnea.

@en

P2093

Alan S Maisel

http://www.w3.org/2001/XMLSchema#string

Alex Harrison

http://www.w3.org/2001/XMLSchema#string

L Katherine Morrison

http://www.w3.org/2001/XMLSchema#string

Padma Krishnaswamy

http://www.w3.org/2001/XMLSchema#string

Patricia Hlavin

http://www.w3.org/2001/XMLSchema#string

Paul Clopton

http://www.w3.org/2001/XMLSchema#string

Quyen Dao

http://www.w3.org/2001/XMLSchema#string

Radmila Kazanegra

http://www.w3.org/2001/XMLSchema#string

P304

131-138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1067/MEM.2002.121483

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11536045

http://www.w3.org/2001/XMLSchema#string

P698

11823766

http://www.w3.org/2001/XMLSchema#string

P921